Variant Phenotype Annotation
证据URL
https://www.pharmgkb.org/variantAnnotation/1444706532
总结
CYP2C9 *1/*2 + *3/*3 + *2/*3 + *1/*3 + *2/*2 are not associated with increased risk of Hemorrhage when treated with acenocoumarol in people with Atrial Fibrillation as compared to CYP2C9 *1/*1.